Suppr超能文献

足部手术和药物治疗对类风湿关节炎功能及疼痛的影响:一项为期五年的纵向研究

Impact of Foot Surgery and Pharmacological Treatments on Functionality and Pain in Rheumatoid Arthritis: A Five-Year Longitudinal Study.

作者信息

Campos-Cano Amparo, Castillo-Dominguez Alejandro, Ortega-Avila Ana-Belen, Ramos-Petersen Laura, Gijon-Nogueron Gabriel, Perez-Galan Maria-Jose, Reinoso-Cobo Andres

机构信息

Department of Nursing and Podiatry, Faculty of Health Sciences, University of Malaga, Arquitecto Francisco Peñalosa 3, Ampliación de Campus de Teatinos, 29071 Malaga, Spain.

IBIMA Plataforma BIONAND, 29010 Malaga, Spain.

出版信息

Healthcare (Basel). 2025 Apr 27;13(9):1004. doi: 10.3390/healthcare13091004.

Abstract

BACKGROUND

Rheumatoid arthritis (RA) frequently leads to foot deformities, significantly impacting pain, mobility, and quality of life. Surgical and pharmacological treatments are prescribed to manage symptoms, but their long-term effects on foot function remain unclear. This study evaluates the impact of different treatment approaches, including surgery, methotrexate (MTX), and biological therapy (Bio), on foot functionality and pain progression over five years.

METHODS

A longitudinal cohort study was conducted with 103 RA patients classified into five groups: surgery, MTX < 10 years, MTX ≥ 10 years, Bio < 10 years, and Bio ≥ 10 years. Data from 2018 and 2023 were compared using the Visual Analog Scale (VAS), the Manchester Foot Pain and Disability Index (MFPDI), and the Foot Function Index (FFI). Statistical analyses included ANOVA, Kruskal-Wallis, and ROC curve analysis to assess differences between groups and identify key progression factors.

RESULTS

Patients with ≥10 years of disease duration and non-biological treatment (MTX ≥ 10 years) experienced the most severe deterioration in foot function, with a mean FFI increase of +11.89 points ( < 0.01). In contrast, MTX < 10 years was the only group to show an improvement in foot function (FFI: -5.29, = 0.02). The surgery group exhibited moderate but highly variable functional changes, while patients on biological therapy showed less progression in pain and disability compared to their non-biologic counterparts. Hallux abductus valgus severity increased across all groups.

CONCLUSIONS

Patients with long-standing RA on non-biologic therapy exhibited the greatest decline in foot function, whereas early treatment with MTX (<10 years of disease duration) appeared to slow deterioration. Surgery did not consistently provide functional benefits, and biologics helped mitigate progression, though outcomes varied. These findings underscore the importance of early intervention and personalized treatment strategies for foot preservation in RA.

摘要

背景

类风湿关节炎(RA)常导致足部畸形,对疼痛、活动能力和生活质量产生重大影响。手术和药物治疗用于控制症状,但其对足部功能的长期影响尚不清楚。本研究评估了包括手术、甲氨蝶呤(MTX)和生物治疗(Bio)在内的不同治疗方法对五年内足部功能和疼痛进展的影响。

方法

对103例RA患者进行了一项纵向队列研究,这些患者分为五组:手术组、病程<10年的MTX组、病程≥10年的MTX组、病程<10年的生物治疗组和病程≥10年的生物治疗组。使用视觉模拟量表(VAS)、曼彻斯特足部疼痛与残疾指数(MFPDI)和足部功能指数(FFI)对2018年和2023年的数据进行比较。统计分析包括方差分析、Kruskal-Wallis检验和ROC曲线分析,以评估组间差异并确定关键进展因素。

结果

病程≥10年且接受非生物治疗(MTX≥10年)的患者足部功能恶化最为严重,平均FFI增加11.89分(<0.01)。相比之下,病程<10年的MTX组是唯一足部功能有所改善的组(FFI:-5.29,=0.02)。手术组表现出中等但高度可变的功能变化,而与非生物治疗患者相比,接受生物治疗的患者疼痛和残疾进展较小。所有组的拇外翻严重程度均增加。

结论

接受非生物治疗的长期RA患者足部功能下降最为明显,而早期使用MTX治疗(病程<10年)似乎减缓了恶化。手术并未始终带来功能益处,生物治疗有助于减轻进展,尽管结果各不相同。这些发现强调了早期干预和个性化治疗策略对RA患者足部保护的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57b5/12071480/a4b4ea6a4812/healthcare-13-01004-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验